# Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers

> **NCT01334697** · PHASE1 · UNKNOWN · sponsor: **Digna Biotech S.L.** · enrollment: 33 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** recombinant human cardiotrophin-1
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01334697
- **Lead sponsor:** Digna Biotech S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-11
- **Primary completion:** 2013-08
- **Final completion:** 2013-08
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2013-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01334697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01334697, "Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Cardiotrophin-1 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01334697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*